Abstract
While radiation therapy (RT) dose escalation improves outcomes in definitive prostate cancer RT, its role in the post-prostatectomy setting has not been established. A major obstacle has been the lack of a clearly defined target resulting in dose escalation to the entire prostate bed (PB), exposure of significant volumes of the bladder and rectum to higher doses, and increased risk of late complications. We hypothesize that there is a dominant tumor focus/foci, that when present determines outcome and that these are the cases/location(s) that would benefit from RT dose escalation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.